Rusnano and Niarmedic: State-owned nanotechnology specialists Rusnano and the Niarmedic pharmaceutical company are looking for partners to invest in an $110m medical campus specialising in endocrinology and ophthalmology on the site of an abandoned hospital in a Moscow suburb. Kommersant